a.mensah
Submits third-party assay reports on material purchased directly. Based in Recife.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.46%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042028 | SS-31 (Elamipretide) | HYB | HYB-2512-B6579 | Janoshik | 2026-Q2 | 99.54 | 1.62 | 92.0 | Buyer-sourced | 0 | PASS |
| AX-2026-042795 | Retatrutide | GGPeps | GGPE-2510-R1919 | Janoshik | 2026-Q1 | 99.05 | 3.21 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043639 | BPC-157 | PPG | PPG-2511-C7828 | Janoshik | 2026-Q1 | 99.65 | 5.45 | 96.6 | Buyer-sourced | 0 | PASS |
| AX-2025-020070 | Thymosin α1 | SWB | SWB-2503-S8299 | Janoshik | 2025-Q3 | 99.75 | 2.93 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020872 | IGF-1 LR3 | WXT | WXT-2508-G2536 | VendorInvestigate | 2025-Q3 | 97.64 | 4.10 | 96.0 | Buyer-sourced | 0 | PASS |
| AX-2025-019442 | MOTS-c | JEEP | JEEP-2507-W7622 | Janoshik | 2025-Q3 | 99.48 | 4.52 | 103.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004592 | Enclomiphene citrate | TFC | TFC-2404-J9626 | Janoshik | 2024-Q3 | 99.44 | 3.91 | 102.6 | Buyer-sourced | 0 | FAIL |
| AX-2024-004447 | Semaglutide | GSP | GSP-2405-W3331 | Janoshik | 2024-Q2 | 99.01 | 3.09 | 96.6 | Buyer-sourced | 0 | PASS |